We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Multimodal molecular imaging in the second near-infrared window

    Menglin Wu

    Tianjin Key Laboratory of Brain Science & Neural Engineering, Academy of Medical Engineering & Translational Medicine, Tianjin University, Tianjin, 300072, China

    Department of Radiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, China

    ,
    Xue Li

    Department of Radiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, China

    ,
    Xiaoyu Mu

    Tianjin Key Laboratory of Brain Science & Neural Engineering, Academy of Medical Engineering & Translational Medicine, Tianjin University, Tianjin, 300072, China

    ,
    Xuening Zhang

    Department of Radiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, China

    ,
    Hao Wang

    *Author for correspondence: Tel.: +86 1375 240 3114;

    E-mail Address: hao_wang@tju.edu.cn

    Tianjin Key Laboratory of Brain Science & Neural Engineering, Academy of Medical Engineering & Translational Medicine, Tianjin University, Tianjin, 300072, China

    &
    Xiao-Dong Zhang

    **Author for correspondence: Tel.: +86 1375 216 8632;

    E-mail Address: xiaodongzhang@tju.edu.cn

    Tianjin Key Laboratory of Brain Science & Neural Engineering, Academy of Medical Engineering & Translational Medicine, Tianjin University, Tianjin, 300072, China

    Department of Physics & Tianjin Key Laboratory of Low Dimensional Materials Physics & Preparing Technology, School of Sciences, Tianjin University, Tianjin, 300350, China

    Published Online:https://doi.org/10.2217/nnm-2022-0124

    Near-infrared-II (NIR-II) fluorescence imaging has rapidly developed for the noninvasive investigation of physiological and pathological activities in living organisms with high spatiotemporal resolution. However, the penetration depth of fluorescence restricts its ability to provide deep anatomical information. Scientists integrate NIR-II fluorescence imaging with other imaging modes (such as photoacoustic and magnetic resonance imaging) to create multimodal imaging that can acquire detailed anatomical and quantitative information with deeper penetration by using multifunctional probes. This review offers a comprehensive picture of NIR-II-based dual/multimodal imaging probes and highlights advances in bioimaging and therapy. In addition, seminal studies and trends in multimodal imaging probes activated by NIR-II laser are summarized and several key points regarding future clinical translation are elucidated.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Wan H, Du H, Wang F, Dai H. Molecular imaging in the second near-infrared window. Adv. Funct. Mater. 29(25), 1900566 (2019).
    • 2. Li C, Wang Q. Challenges and opportunities for intravital near-infrared fluorescence imaging technology in the second transparency window. ACS Nano 12(10), 9654–9659 (2018).
    • 3. Vahrmeijer AL, Hutteman M, Van Der Vorst JR, Van De Velde CJ, Frangioni JV. Image-guided cancer surgery using near-infrared fluorescence. Nat. Rev. Clin. Oncol. 10(9), 507–518 (2013).
    • 4. Zhang XD, Luo Z, Chen J et al. Ultrasmall glutathione-protected gold nanoclusters as next generation radiotherapy sensitizers with high tumor uptake and high renal clearance. Sci. Rep. 5, 8669 (2015).
    • 5. Zhang XD, Luo Z, Chen J et al. Ultrasmall Au(10–12)(SG)(10–12) nanomolecules for high tumor specificity and cancer radiotherapy. Adv. Mater. 26(26), 4565–4568 (2014).
    • 6. Zhang XD, Chen J, Yang J et al. Use of epidermal growth factor receptor antibody-gold cluster conjugates with good renal excretion in targeted cancer radiation treatment. J. Mater. Chem. B 3(23), 4735–4741 (2015).
    • 7. Shinn J, Lee S, Lee HK et al. Recent progress in development and applications of second near-infrared (NIR-II) nanoprobes. Arch. Pharm. Res. 44(2), 165–181 (2021).
    • 8. He S, Song J, Qu J, Cheng Z. Crucial breakthrough of second near-infrared biological window fluorophores: design and synthesis toward multimodal imaging and theranostics. Chem. Soc. Rev. 47(12), 4258–4278 (2018).
    • 9. Xu W, Wang D, Tang BZ. NIR-II AIEgens: a win-win integration towards bioapplications. Angew Chem. Int. Ed. Engl. 60(14), 7476–7487 (2021).
    • 10. Antaris AL, Chen H, Cheng K et al. A small-molecule dye for NIR-II imaging. Nat. Mater. 15(2), 235–242 (2016).
    • 11. Wang X, He H, Wang Y et al. Active tumor-targeting luminescent gold clusters with efficient urinary excretion. Chem. Commun. (Camb). 52(59), 9232–9235 (2016).
    • 12. Bai X, Wang J, Mu X et al. Ultrasmall WS2 quantum dots with visible fluorescence for protection of cells and animal models from radiation-induced damages. ACS Biomater. Sci. Eng. 3(3), 460–470 (2017).
    • 13. He H, Liu X, Li S et al. High-density super-resolution localization imaging with blinking carbon dots. Anal. Chem. 89(21), 11831–11838 (2017).
    • 14. Hao W, Mu X, Jiang Y, Liang Y, Dong M. Brain imaging with near-infrared fluorophores. Coordin. Chem. Rev. 380, 550–571 (2019).
    • 15. Chen J, Liu L, Liu H, Li Y, Zhang XD. Ultrabright bimetallic AuAg complex: from luminescence mechanism to biological application. J. Innov. Opt. Heal. Sci. 13(5), 73–85 (2020).
    • 16. Chen J, Qiao Y, Li Y, Liu T, Zhang XD. Fluorescence enhancement of water-soluble silver nanoclusters via Au doping. AIP Adv. 10(12), 125103 (2020).
    • 17. Yanqingqiao, Yingliu, Haixialiu et al. Fluorescence enhancement of gold nanoclusters via Zn doping for biomedical applications. RSC Adv. 8(14), 7396–7402 (2018).
    • 18. Zhang XD, Wang H, Antaris AL et al. Traumatic brain injury imaging in the second near-infrared window with a molecular fluorophore. Adv. Mater. 28(32), 6872–6879 (2016).
    • 19. Yang Q, Ma Z, Wang H et al. Rational design of molecular fluorophores for biological imaging in the NIR-II window. Adv. Mater. 29(12), 1605497 (2017).
    • 20. Liu S, Zhang XD, Gu X, Ming D. Photodetectors based on two dimensional materials for biomedical application. Biosens. Bioelectron. 143, 111617 (2019).
    • 21. Kenry, Duan Y, Liu B. Recent advances of optical imaging in the second near-infrared window. Adv. Mater. 30(47), e1802394 (2018).
    • 22. Liu H, Hong G, Luo Z et al. Atomic-precision gold clusters for NIR-II imaging. Adv. Mater. 31(46), e1901015 (2019).
    • 23. Tian R, Zeng Q, Zhu S et al. Albumin-chaperoned cyanine dye yields superbright NIR-II fluorophore with enhanced pharmacokinetics. Sci. Adv. 5(9), eaaw0672 (2019).
    • 24. Huang J, Xie C, Zhang X et al. Renal-clearable molecular semiconductor for second near-infrared fluorescence imaging of kidney dysfunction. Angew Chem. Int. Ed. Engl. 58(42), 15120–15127 (2019).
    • 25. Liu P, Mu X, Zhang XD, Ming D. The near-infrared-II fluorophores and advanced microscopy technologies development and application in bioimaging. Bioconjug. Chem. 31(2), 260–275 (2020).
    • 26. Wan H, Yue J, Zhu S et al. A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues. Nat. Commun. 9(1), 1171 (2018).
    • 27. Smith AM, Mancini MC, Nie S. Bioimaging: second window for in vivo imaging. Nat. Nanotechnol. 4(11), 710–711 (2009).
    • 28. Ma Z, Wan H, Wang W et al. A theranostic agent for cancer therapy and imaging in the second near-infrared window. Nano Res. 12, 273–279 (2019).
    • 29. Yang Y, Yu Y, Chen H et al. Illuminating platinum transportation while maximizing therapeutic efficacy by gold nanoclusters via simultaneous near-infrared-I/II imaging and glutathione scavenging. ACS Nano 14(10), 13536–13547 (2020).
    • 30. Wei D, Yu Y, Huang Y et al. A near-infrared-II polymer with tandem fluorophores demonstrates superior biodegradability for simultaneous drug tracking and treatment efficacy feedback. ACS Nano 15(3), 5428–5438 (2021).
    • 31. Yang K, Liu T, Zhang XD. Bandgap engineering and near-infrared-II optical properties of monolayer MoS2: a first-principle study. Front. Chem. 9, 700250 (2021).
    • 32. Hong G, Antaris AL, Dai H. Near-infrared fluorophores for biomedical imaging. Nat. Biomed. Eng. 1(1), 0010 (2017).
    • 33. Wang S, Li B, Zhang F. Molecular fluorophores for deep-tissue bioimaging. ACS Cent. Sci. 6(8), 1302–1316 (2020).
    • 34. Zhong Y, Ma Z, Wang F et al. In vivo molecular imaging for immunotherapy using ultra-bright near-Infrared-IIb rare-earth nanoparticles. Nat. Biotechnol. 37(11), 1322–1331 (2019).
    • 35. Li X, Li J, Li C et al. Aminopeptidase N-targeting nanomolecule-assisted delivery of VEGF siRNA to potentiate antitumour therapy by suppressing tumour revascularization and enhancing radiation response. J. Mater. Chem. B 9(36), 7530–7543 (2021).
    • 36. Li X, Wu M, Wang J et al. Ultrasmall bimodal nanomolecules enhanced tumor angiogenesis contrast with endothelial cell targeting and molecular pharmacokinetics. Nanomedicine 15(1), 252–263 (2019).
    • 37. Wu M, Li X, Guo Q et al. Magnetic mesoporous silica nanoparticles-aided dual MR/NIRF imaging to identify macrophage enrichment in atherosclerotic plaques. Nanomedicine 32, 102330 (2021).
    • 38. Wang J, Wu M, Chang J et al. Scavenger receptor-AI-targeted ultrasmall gold nanoclusters facilitate in vivo MR and ex vivo fluorescence dual-modality visualization of vulnerable atherosclerotic plaques. Nanomedicine 19, 81–94 (2019).
    • 39. Xu J, Shi R, Chen G et al. All-in-one theranostic nanomedicine with ultrabright second near-infrared emission for tumor-modulated bioimaging and chemodynamic/photodynamic therapy. ACS Nano 14(8), 9613–9625 (2020).
    • 40. Liu Y, Fan H, Guo Q, Jiang A, Du X, Zhou J. Ultra-small pH-responsive Nd-doped NaDyF4 nanoagents for enhanced cancer theranostic by in situ aggregation. Theranostics 7(17), 4217–4228 (2017).
    • 41. Li X, Zhang XN, Li XD, Chang J. Multimodality imaging in nanomedicine and nanotheranostics. Cancer Biol. Med. 13(3), 339–348 (2016).
    • 42. Liu Y, Zhen W, Wang Y et al. Double switch biodegradable porous hollow trinickel monophosphide nanospheres for multimodal imaging guided photothermal therapy. Nano Lett. 19(8), 5093–5101 (2019).
    • 43. Jiang Y, Pu K. Molecular fluorescence and photoacoustic imaging in the second near-infrared optical window using organic contrast agents. Adv. Biosyst. 2(5), e1700262 (2018).
    • 44. Sun Y, Zeng X, Xiao Y et al. Novel dual-function near-infrared II fluorescence and PET probe for tumor delineation and image-guided surgery. Chem. Sci. 9(8), 2092–2097 (2018).
    • 45. Li X, Fang F, Sun B et al. Near-infrared small molecule coupled with rigidness and flexibility for high-performance multimodal imaging-guided photodynamic and photothermal synergistic therapy. Nanoscale Horiz. 6(2), 177–185 (2021). •• It was very unusual that acceptor-donor-acceptor-structured small-molecule-based nanoparticles made each function balanced and maximized, since the energies required to simultaneously carry out photodynamic therapy, photothermal therapy/photoacoustic imaging and near-infrared-II fluorescence imaging were competing.
    • 46. Li X, Jiang M, Li Y, Xue Z, Zeng S, Liu H. 808 nm laser-triggered NIR-II emissive rare-earth nanoprobes for small tumor detection and blood vessel imaging. Mater. Sci. Eng. C Mater. Biol. Appl. 100, 260–268 (2019).
    • 47. Wu C, Zhang Y, Li Z, Li C, Wang Q. A novel photoacoustic nanoprobe of ICG@PEG-Ag2S for atherosclerosis targeting and imaging in vivo. Nanoscale 8(25), 12531–12539 (2016).
    • 48. Zhao M, Ding J, Mao Q et al. A novel αvβ3 integrin-targeted NIR-II nanoprobe for multimodal imaging-guided photothermal therapy of tumors in vivo. Nanoscale 12(13), 6953–6958 (2020).
    • 49. Dai Y, Yang D, Yu D et al. Mussel-inspired polydopamine-coated lanthanide nanoparticles for NIR-II/CT dual imaging and photothermal therapy. ACS Appl. Mater. Interfaces 9(32), 26674–26683 (2017).
    • 50. Zheng Z, Chen Q, Dai R et al. A Continuous stimuli-responsive system for NIR-II fluorescence/photoacoustic imaging-guided photothermal/gas synergistic therapy. Nanoscale 12(21), 11562–11572 (2020).
    • 51. Zhang Z, Xu W, Kang M et al. An all-round athlete on the track of phototheranostics: subtly regulating the balance between radiative and nonradiative decays for multimodal imaging-guided synergistic therapy. Adv. Mater. 32(36), e2003210 (2020).
    • 52. Sun J, Cai W, Sun Y, Guo C, Zhang R. Facile synthesis of melanin-dye nanoagent for NIR-II fluorescence/photoacoustic imaging-guided photothermal therapy. Int. J. Nanomed. 15, 10199–10213 (2020).
    • 53. Li S, Chen H, Liu H et al. In vivo real-time pharmaceutical evaluations of near-infrared II fluorescent nanomedicine bound polyethylene glycol ligands for tumor photothermal ablation. ACS Nano 14(10), 13681–13690 (2020).
    • 54. Cai W, Sun J, Sun Y et al. NIR-II FL/PA dual-modal imaging long-term tracking of human umbilical cord-derived mesenchymal stem cells labeled with melanin nanoparticles and visible HUMSC-based liver regeneration for acute liver failure. Biomater Sci. 8(23), 6592–6602 (2020).
    • 55. Zhang Y, Tao H, Li Q et al. Surfactant-stripped J-aggregates of azabodipy derivatives: all-in-one phototheranostics in the second near infrared window. J. Control. Release 326, 256–264 (2020).
    • 56. Li J, Jiang R, Wang Q et al. Semiconducting polymer nanotheranostics for NIR-II/photoacoustic imaging-guided photothermal initiated nitric oxide/photothermal therapy. Biomaterials 217, 119304 (2019).
    • 57. Guo B, Feng Z, Hu D et al. Precise deciphering of brain vasculatures and microscopic tumors with dual NIR-II fluorescence and photoacoustic imaging. Adv. Mater. 31(30), e1902504 (2019).
    • 58. Cheng K, Chen H, Jenkins CH et al. Synthesis, characterization, and biomedical applications of a targeted dual-modal near-infrared-II fluorescence and photoacoustic imaging nanoprobe. ACS Nano 11(12), 12276–12291 (2017).
    • 59. Zhang X, Wang W, Su L et al. Plasmonic-fluorescent Janus Ag/Ag2S nanoparticles for in situ H2O2-activated NIR-II fluorescence imaging. Nano Lett. 21(6), 2625–2633 (2021). •• Compared with traditional imaging, activatable imaging methods can take advantage of specific disease characteristics for more accurate diagnosis.
    • 60. Zheng Z, Dai R, Jia Z et al. Biodegradable multifunctional nanotheranostic based on Ag2S-doped hollow BSA-SiO2 for enhancing ROS-feedback synergistic antitumor therapy. ACS Appl. Mater. Interfaces 12(49), 54356–54366 (2020).
    • 61. Zhao DH, Yang XQ, Hou XL et al. In situ aqueous synthesis of genetically engineered polypeptide-capped Ag2S quantum dots for second near-infrared fluorescence/photoacoustic imaging and photothermal therapy. J. Mater. Chem. B 7(15), 2484–2492 (2019).
    • 62. Yang T, Tang Y, Liu L et al. Size-dependent Ag2S nanodots for second near-infrared fluorescence/photoacoustics imaging and simultaneous photothermal therapy. ACS Nano 11(2), 1848–1857 (2017).
    • 63. Wu J, Liu J, Lin B, Lv R, Yuan Y, Tao X. Met-targeted dual-modal MRI/NIR II imaging for specific recognition of head and neck squamous cell carcinoma. ACS Biomater. Sci. Eng. 7(4), 1640–1650 (2021).
    • 64. Okubo K, Takeda R, Murayama S et al. Size-controlled bimodal in vivo nanoprobes as near-infrared phosphors and positive contrast agents for magnetic resonance imaging. Sci. Technol. Adv. Mater. 22(1), 160–172 (2021).
    • 65. Ren Y, He S, Huttad L et al. An NIR-II/MR dual modal nanoprobe for liver cancer imaging. Nanoscale 12(21), 11510–11517 (2020).
    • 66. Dong Y, Dong S, Wang Z et al. Multimode imaging-guided photothermal/chemodynamic synergistic therapy nanoagent with a tumor microenvironment responded effect. ACS Appl. Mater. Interfaces 12(47), 52479–52491 (2020).
    • 67. Li Y, Li X, Xue Z, Jiang M, Zeng S, Hao J. Second near-infrared emissive lanthanide complex for fast renal-clearable in vivo optical bioimaging and tiny tumor detection. Biomaterials 169, 35–44 (2018).
    • 68. Ren F, Ding L, Liu H et al. Ultra-small nanocluster mediated synthesis of Nd3+-doped core-shell nanocrystals with emission in the second near-infrared window for multimodal imaging of tumor vasculature. Biomaterials 175, 30–43 (2018).
    • 69. Xu Y, Ren F, Liu H et al. Cholesterol-modified black phosphorus nanospheres for the first NIR-II fluorescence bioimaging. ACS Appl. Mater. Interfaces 11(24), 21399–21407 (2019).
    • 70. Hu X, Chen Z, Jin AJ et al. Rational design of all-organic nanoplatform for highly efficient MR/NIR-II imaging-guided cancer phototheranostics. Small 17(12), e2007566 (2021).
    • 71. Zheng Z, Jia Z, Qu C et al. Biodegradable silica-based nanotheranostics for precise MRI/NIR-II fluorescence imaging and self-reinforcing antitumor therapy. Small 17(10), e2006508 (2021).
    • 72. Zhang X, Zhao M, Wen L et al. Sequential SPECT and NIR-II imaging of tumor and sentinel lymph node metastasis for diagnosis and image-guided surgery. Biomater. Sci. 9(8), 3069–3075 (2021).
    • 73. Zhang X, Ding B, Qu C et al. A thiopyrylium salt for PET/NIR-II tumor imaging and image-guided surgery. Mol. Oncol. 14(5), 1089–1100 (2020).
    • 74. Ge X, Fu Q, Su L et al. Light-activated gold nanorod vesicles with NIR-II fluorescence and photoacoustic imaging performances for cancer theranostics. Theranostics 10(11), 4809–4821 (2020).
    • 75. Ma L, Huang S, He S, Wang Z, Cheng Z. Polydopamine-coated downconversion nanoparticle as an efficient dual-modal near-infrared-II fluorescence and photoacoustic contrast agent for non-invasive visualization of gastrointestinal tract in vivo. Biosens. Bioelectron. 151, 112000 (2020).
    • 76. Bhardwaj K, Pradhan S, Basel S, Clarke M, Brito B. Tunable NIR-II emitting silver chalcogenide quantum dots using thio/selenourea precursors: preparation of an MRI/NIR-II multimodal imaging agent. Dalton Trans. 49(43), 15425–15432 (2020).
    • 77. Sun Y, Ding F, Chen Z et al. Melanin-dot-mediated delivery of metallacycle for NIR-II/photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy. Proc. Natl Acad. Sci. USA 116(34), 16729–16735 (2019).
    • 78. Zhang Q, Zhou H, Chen H et al. Hierarchically nanostructured hybrid platform for tumor delineation and image-guided surgery via NIR-II fluorescence and PET bimodal imaging. Small 15(45), e1903382 (2019).
    • 79. Ma JJ, Yu MX, Zhang Z et al. Gd-DTPA-coupled Ag2Se quantum dots for dual-modality magnetic resonance imaging and fluorescence imaging in the second near-infrared window. Nanoscale 10(22), 10699–10704 (2018).
    • 80. Shi J, Sun X, Zheng S, Li J, Fu X, Zhang H. A new near-infrared persistent luminescence nanoparticle as a multifunctional nanoplatform for multimodal imaging and cancer therapy. Biomaterials 152, 15–23 (2018).
    • 81. Mishra SK, Kannan S. Microwave synthesis of chitosan capped silver-dysprosium bimetallic nanoparticles: a potential nanotheranosis device. Langmuir 32(51), 13687–13696 (2016).
    • 82. Qin MY, Yang XQ, Wang K et al. In vivo cancer targeting and fluorescence-CT dual-mode imaging with nanoprobes based on silver sulfide quantum dots and iodinated oil. Nanoscale 7(46), 19484–19492 (2015).
    • 83. Li C, Cao L, Zhang Y et al. Preoperative detection and intraoperative visualization of brain tumors for more precise surgery: a new dual-modality MRI and NIR nanoprobe. Small 11(35), 4517–4525 (2015).
    • 84. Jia Q, Ge J, Liu W et al. Gold nanorod@silica-carbon dots as multifunctional phototheranostics for fluorescence and photoacoustic imaging-guided synergistic photodynamic/photothermal therapy. Nanoscale 8(26), 13067–13077 (2016).
    • 85. Lartigue L, Coupeau M, Lesault M. Luminophore and magnetic multicore nanoassemblies for dual-mode MRI and fluorescence imaging. Nanomaterials (Basel) 10(1), 28 (2019).
    • 86. Cao J, Zhu B, Zheng K et al. Recent progress in NIR-II contrast agent for biological imaging. Front. Bioeng. Biotechnol. 7, 487 (2020).
    • 87. Feng F, Liu L, Yang Q, Wang S. Water-soluble conjugated polymers for fluorescent-enzyme assays. Macromol. Rapid Commun. 31(16), 1405–1421 (2010).
    • 88. Miao Q, Pu K. Organic semiconducting agents for deep-tissue molecular imaging: second near-infrared fluorescence, self-luminescence, and photoacoustics. Adv. Mater. 30(49), e1801778 (2018).
    • 89. Mei J, Leung NL, Kwok RT, Lam JW, Tang BZ. Aggregation-induced emission: together we shine, united we soar! Chem. Rev. 115(21), 11718–11940 (2015).
    • 90. Wang Q, Dai Y, Xu J et al. All-in-one phototheranostics: single laser triggers NIR-II fluorescence/photoacoustic imaging-guided photothermal/photodynamic/chemo combination therapy. Adv. Funct. Mater. 29(31), 1901480.1–1901480.12 (2019).
    • 91. Yang L, Zhu X, Xu T et al. Defect-engineered transition metal hydroxide nanosheets realizing tumor-microenvironment-responsive multimodal-imaging-guided NIR-II photothermal therapy. J. Mater. Chem. B 8(36), 8323–8336 (2020).
    • 92. Cao Y, Wu T, Zhang K et al. Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photothermal therapy. ACS Nano 13(2), 1499–1510 (2019).
    • 93. Cheng Y, Yang F, Xiang G et al. Ultrathin tellurium oxide/ammonium tungsten bronze nanoribbon for multimodality imaging and second near-infrared region photothermal therapy. Nano Lett. 19(2), 1179–1189 (2019).
    • 94. Deng X, Liang S, Cai X et al. Yolk-shell structured au nanostar@metal-organic framework for synergistic chemo-photothermal therapy in the second near-infrared window. Nano Lett. 19(10), 6772–6780 (2019).
    • 95. Cai K, Zhang W, Zhang J, Li H, Han H, Zhai T. Design of gold hollow nanorods with controllable aspect ratio for multimodal imaging and combined chemo-photothermal therapy in the second near-infrared window. ACS Appl. Mater. Interfaces 10(43), 36703–36710 (2018).
    • 96. Ma Q, Cheng L, Gong F et al. Platinum nanoworms for imaging-guided combined cancer therapy in the second near-infrared window. J. Mater. Chem. B 6(31), 5069–5079 (2018).
    • 97. He T, Jiang C, He J et al. Manganese-dioxide-coating-instructed plasmonic modulation of gold nanorods for activatable duplex-imaging-guided NIR-II photothermal-chemodynamic therapy. Adv. Mater. 33(13), 2008540 (2021). • The progress of photoacoustic imaging in the near-infrared-II window has gained immense attention due to larger maximum permissible exposure under 1064 nm, desirable tissue penetration depth and sensitivity.
    • 98. Liu Y, Liu H, Yan H et al. Aggregation-induced absorption enhancement for deep near-infrared II photoacoustic imaging of brain gliomas in vivo. Adv. Sci. (Weinh). 6(8), 1801615 (2019).
    • 99. Li Y, Lin J, Wang P et al. Tumor microenvironment responsive shape-reversal self-targeting virus-inspired nanodrug for imaging-guided near-infrared-II photothermal chemotherapy. ACS Nano 13(11), 12912–12928 (2019).
    • 100. Ma HZ, Wang JY, Zhang XD. Near-infrared II emissive metal clusters: from atom physics to biomedicine. Coordin. Chem. Rev. 448, 214184 (2021).
    • 101. Zhang XD, Wu D, Shen X et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 33(27), 6408–6419 (2012).
    • 102. Zhao R, Liu H, Li Y, Guo M, Zhang XD. Catalytic nanozyme for radiation protection. Bioconjug. Chem. 32(3), 411–429 (2021).
    • 103. Zhang Y, Sun S, Liu H et al. Catalytically active gold clusters with atomic precision for noninvasive early intervention of neurotrauma. J. Nanobiotechnol. 19(1), 319 (2021).
    • 104. Zhang Y, Ni S, Chong C, Xu J, Zhang XD. Biocatalysts at atom level: from coordination structure to medical applications. Appl. Mater. Today 23, 101029 (2021).
    • 105. Sun S, Liu H, Xin Q et al. Atomic engineering of clusterzyme for relieving acute neuroinflammation through lattice expansion. Nano Lett. 21(6), 2562–2571 (2021).
    • 106. Zhang Y, Li S, Liu H, Long W, Zhang XD. Enzyme-like properties of gold clusters for biomedical application. Front. Chem. 8, 219 (2020).
    • 107. Pei J, Zhao R, Mu X, Wang J, Liu C, Zhang XD. Single-atom nanozymes for biological applications. Biomater. Sci. 8(23), 6428–6441 (2020).
    • 108. Bian P, Zhang J, Wang J et al. Enhanced catalysis of ultrasmall Au-MoS2 clusters against reactive oxygen species for radiation protection. Sci. Bull. 63(14), 925–934 (2018).
    • 109. Yan R, Sun S, Yang J et al. Nanozyme-based bandage with single-atom catalysis for brain trauma. ACS Nano 13(10), 11552–11560 (2019).
    • 110. Cheng L, Wang X, Gong F, Liu T, Liu Z. 2D nanomaterials for cancer theranostic applications. Adv. Mater. 32(13), 1902333 (2019).
    • 111. Mccarthy L, Verma G, Hangel G et al. Application of 7T MRS to high-grade gliomas. AJNR Am. J. Neuroradiol. (2022) (Epub ahead of print).
    • 112. Tan MT, Lloyd TB. Utility of dual energy computed tomography in the evaluation of infiltrative skeletal lesions and metastasis: a literature review. Skeletal Radiol. 51(9), 1731–1741 (2022).
    • 113. Hughes DJ, Subesinghe M, Taylor B et al. 18F FDG PET/CT and novel molecular imaging for directing immunotherapy in cancer. Radiology 304(2), 246–264 (2022).